Skip to main content
MS disease activity in RESTORE: A randomized 24-week natalizumab treatment interruption study
Published Web Location
http://europepmc.org/articles/PMC4011468?pdf=renderNo data is associated with this publication.
Abstract
Objective: RESTORE was a randomized, partially placebo-controlled exploratory study evaluating multiple sclerosis (MS) disease activity during a 24-week interruption of natalizumab. Methods: Eligible patients were relapse-free through the prior year on nat
Many UC-authored scholarly publications are freely available on this site because of the UC's open access policies. Let us know how this access is important for you.